PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31756041-2	2019	Rosiglitazone(RSG), a widely used antidiabetic drug that activates peroxisome proliferator-activated receptor-gamma (PPAR-gamma), has been shown to protect against cerebral ischemia through promoting poststroke microglial polarization toward the beneficial anti-inflammatory phenotype.	rsg	14-17	peroxisome proliferator activated receptor gamma	Mus musculus	67-115	
31756041-2	2019	Rosiglitazone(RSG), a widely used antidiabetic drug that activates peroxisome proliferator-activated receptor-gamma (PPAR-gamma), has been shown to protect against cerebral ischemia through promoting poststroke microglial polarization toward the beneficial anti-inflammatory phenotype.	rsg	14-17	peroxisome proliferator activated receptor gamma	Mus musculus	117-127	
31756041-9	2019	We further found that the expression of Arg-1 was also upregulated in those tPA and RSG-treated stroke mice and the protection against tPA-induced HT and BBB disruption in these mice were abolished in the presence of PPAR-gamma antagonist GW9662 (4 mg/kg, 1 hour before dMCAO through intraperitoneal injection).	rsg	84-87	peroxisome proliferator activated receptor gamma	Mus musculus	217-227	
31756041-10	2019	CONCLUSIONS: RSG treatment protects against BBB damage and ameliorates HT in delayed tPA-treated stroke mice by activating PPAR-gamma and favoring microglial polarization toward anti-inflammatory phenotype.	rsg	13-16	peroxisome proliferator activated receptor gamma	Mus musculus	123-133